Beatriz Soldevilla

6PUBLICATIONS
32CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Medical biochemistry - amino acids and metabolitesCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 20, 2026
Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).

Rocio Garcia-Carbonero, Marta Benavent, Paula Jimenez-Fonseca

|Jun 06, 2025
Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer.

Beatriz Rubio-Cuesta, Carlos Carretero-Puche, Patricia Llamas

|Jan 17, 2025
NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations.

Po Hien Ear, Ilaria Marinoni, Talya Dayton

|Nov 30, 2023
Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival.

Anna La Salvia, Alberto Lens-Pardo, Angel López-López

|Mar 07, 2023
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?

Rocio Garcia-Carbonero, Beatriz Anton-Pascual, Andrea Modrego

|Feb 16, 2023
MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms.

Beatriz Soldevilla, Alberto Lens-Pardo, Paula Espinosa-Olarte

Pageof 1

Frequent Collaborators

4 joint publications

Rocio Garcia-Carbonero

3 joint publications

Alberto Lens-Pardo

1 joint publications

Yolanda Rodriguez-Gil

1 joint publications

Ana Teijo-Quintans